Breaking
October 11, 2026

Health

India’s Most Comprehensive Heart and Lung Transplant Program Gives Critically Ill Patients a Second Chance at Life

Chennai, 22 January 2026: Apollo Hospitals, Chennai continues to set national benchmarks in the treatment of advanced heart and lung disease, driven by one of India’s most comprehensive heart, lung, and ECMO-supported transplant programs. The transplant team, with significant national and international experience, have performed 600+ heart and lung transplants, managed over 2,000 transplant patients, 1,000+ Extracorporeal Membrane Oxygenation (ECMO) cases, along with 250+ Left Ventricular Assist Devices (LVAD) procedures and 250+ Chronic Thromboembolic Pulmonary Hypertension (CTEPH) interventions.

The multidisciplinary heart-lung transplant and MCS program at Apollo expertly manages patients with end-stage heart and or lung failure, offering personalised solutions for those who no longer respond to maximal medical therapy. Be it a stabilising, bridging or definitive treatment with transplanting hearts and lungs, or implanting durable mechanical cardiac pumps for failing hearts, our patients are supported through a continuum of focused and evidence-based care.

The team also offers comprehensive solutions for even the most complex cardiopulmonary conditions, such as the gold standard treatment of Pulmonary Endarterectomy (PEA) for appropriate patients with CTEPH, where the chronic blood clots in the lung arteries are removed surgically.

The press conference held to mark this milestone featured patients from different age groups and levels of illness severity, who shared how their lives were transformed by the program. Among them were Mr. Raja Sivagurunathan (59), who survived a critical phase on ECMO support for 48 days before undergoing an emergency double-lung transplant; Mr. B. Saravanan (45), who developed sudden and severe lung failure and was supported on life-saving machines for two weeks until a successful lung transplant; and Mr. Radhae Shyam Raghuvanshi (72), whose condition worsened abruptly and who was airlifted to Chennai before receiving a double-lung transplant after advanced support.

Commenting about ECMO and Transplantation, Dr. Srinivas Rajagopala, Senior Consultant & Clinical Lead – Pulmonology, Sleep Medicine and Lung Transplant, Apollo Hospitals Chennai said, “These outcomes demonstrate how early and appropriate use of ECMO can fundamentally alter the course of severe lung failure. It provides a vital bridge allowing time for stabilisation, informed decision-making, and preparation for lung transplantation. Success lies in constant vigilance, multidisciplinary teamwork, and highly personalized care. Our goal is always meaningful recovery, not merely short-term survival.”

Dr. Kumud Kumar Dhital, Head of Heart and Lung Transplantation at Apollo Hospitals, Chennai, emphasized “Patients suffering from advancing heart and lung failure, with escalating medical therapy and declining quality of life, deserve to be informed of the transplant options at a far earlier stage. Outcomes improve significantly when patients are referred early and managed with strong, protocol-driven hospital care. Age itself is not a limitation – what matters is careful evaluation, optimization, meticulous surgery, expert after-care in the ICU, and life-long post-discharge continuity of care so as to maximize chances of long-term survivorship.”

Dr. IIankumaran Kaliamoorthy, CEO – Chennai Region, Apollo Hospitals also participated in the press conference.

As India’s burden of advanced heart and lung disease continues to rise, Apollo Hospitals remains at the forefront of comprehensive cardiothoracic transplantation, combining innovation, expertise, and compassionate care- proving that even the most critical organ failure can be transformed into a second chance at life.

Apollo Hospitals delivers 360-degree care through an integrated, multidisciplinary model involving cardiology, pulmonology, cardiothoracic surgery, anaesthesia, critical care, transplant coordination, rehabilitation, and seamlessly coordinates this with post-discharge and long-term follow-up. The program’s focus extends beyond survival to restoring functional independence and quality of life for patients while fully informing and supporting their families.

ECMO serves as a vital life-support technology within this ecosystem. This mechanical support temporarily takes over the function of the heart and/or lungs when conventional therapies fail. By oxygenating blood outside the body, ECMO allows failing organs to rest and recover or acts as a crucial bridge to recovery or transplantation. The program integrates VV-ECMO for lung support, VA-ECMO for cardiac and combined heart-lung failure. LVADs in the form of implantable and mechanical heart pumps are offered to suitable candidates as durable alternatives or bridge to heart transplantation.

SIMS Hospital Unveils India’s First 24×7 Digital Medical Bus for Rural Communities

Chennai, January , 2026: SIMS Hospital has unveiled SIMS Hello Doctor Health on Wheels, India’s first medical bus designed to deliver essential and comprehensive medical services and teleconsultations with specialists to rural communities. Health on Wheels offers on-the-go consultations, health screenings, vaccinations, and basic diagnostic services backed by a 24×7 medical team.

Thiru. Ma. Subramanian, Hon’ble Minister for Health & Medical Education, Government of Tamil Nadu, flagged off the medical bus in the presence of Tmt. Tamilachi Thangapandiyan, Member of Parliament, South Chennai Constituency, Thiru. A.M.V. Prabhakara Raja, Member of Legislative Assembly, Virugambakkam Constituency, and Dr. Ravi Pachamuthu, Chairman, SRM Group.

The mobile unit enables seamless and paperless end-to-end patient care, including registration, consultation, diagnostics, referrals, and follow-ups, ensuring that individuals receive quality medical attention without the burden of travel or long waiting times. The medical bus provides a wide spectrum of services such as real-time mobile teleconsultations with specialists and super-specialists, vaccination-on-wheels to improve immunisation access and coverage, and one-stop preventive health check-ups for early risk identification.

With a strong focus on preventive healthcare and wellness, SIMS Hello Doctor also facilitates early assessment and detection of non-communicable diseases, particularly in rural and underserved communities.

As part of its operations, the SIMS Hello Doctor medical bus will conduct exclusive health screenings and check-ups across industries, schools, colleges, and rural communities. The medical bus also delivers smart health education and awareness sessions aimed at promoting healthy lifestyles, early intervention, and informed healthcare decisions. An AI-powered chatbot further enhances patient engagement by offering guided assistance, appointment support, and access to verified health information. Under its Mission SIMS VILLAGE framework, the hospital will identify villages through the medical bus to ensure continuous access to preventive, diagnostic, and consultative healthcare services, while strengthening grassroots healthcare delivery on a call to 044 2001 2001.

Speaking on the occasion, Thiru. Ma. Subramanian, Hon’ble Minister for Health & Medical Education, Government of Tamil Nadu, said, “Initiatives such as Hello Doctor Health on Wheels play an important role in strengthening the public healthcare ecosystem by ensuring that medical services reach people where they live. This step signifies the future of healthcare—one that is inclusive, preventive, and accessible. I appreciate SIMS Hospital for taking this forward towards community well-being.”

Commenting on the launch, Tmt. Tamilachi Thangapandiyan said, “Tamil Nadu has gained a global recognition as a preferred destination for medical tourism, offering advanced treatments, skilled doctors. Growing number of foreign patients are choosing Tamil Nadu for affordable and high-quality medical care, strengthening state’s position as a leading healthcare hub in India. I also commend Mr. Ravi Pachamuthu and the SIMS Hospital team for their consistent efforts in delivering quality healthcare services to rural communities, ensuring equitable access to medical care for all.”

Dr. Ravi Pachamuthu, Chairman, SRM Group, said, “At SIMS Hospital, our vision has always been to go beyond hospital walls and reach patients where they need us the most. SIMS Hello Doctor – Health on Wheels reflects our commitment to preventive healthcare, early intervention, and technology-driven care. This 24×7 mobile healthcare service will not only improve health outcomes but also empower communities with awareness and timely medical guidance.” This initiative marks a significant step in redefining healthcare delivery through innovation, outreach, and community-centric care, paving the way for a future where timely and quality medical support is always within reach.

MGM Cancer Institute Saves 41-Year-Old Man with Advanced, Inoperable Tongue Cancer

Chennai, January 6, 2026: Doctors at MGM Cancer Institute have successfully treated a 41-year-old male smoker with advanced tongue cancer (squamous cell carcinoma), a condition previously considered inoperable at several hospitals as the tumour, measuring approximately 5 × 3 cm with significant vertical extension, had spread across the entire anterior tongue, the floor of the mouth, and reached the hyoid bone, a bone in the upper neck that supports the tongue.

The patient underwent a composite resection, a single, extensive surgery aimed at removing all cancer-affected tissue. This included complete removal of the front portion of the tongue (anterior total glossectomy), removal of cancer-involved tissue from the floor of the mouth, and removal of the affected portion of the jaw bone (segmental mandibulectomy). The procedure also required removal of the hyoid bone.

Following complete tumour removal, doctors rebuilt the tongue and mouth using free flap reconstruction, an advanced technique in which healthy tissue from another part of the body was used to restore normal shape and function. As a final step, radiation therapy was administered to eliminate any remaining cancer cells at the microscopic level, ensuring complete cancer control.

The complex medical and surgical procedures were carried out by a multidisciplinary team comprising Dr. M.A. Raja, Director and Senior consultant – Medical Oncology; Dr. Sivaram Ganesamoni, HOD and Senior Consultant, Surgical Oncology; Dr. Manikandan Venkatasubramaniyan, Senior Consultant, Surgical Oncology; Dr. A. Siva Kumar, Plastic Surgeon.

Commenting on the case, Dr. Raja said, “The patient, a known smoker, presented with a persistent ulcer and abnormal growth on the tongue. Clinical examination revealed extensive involvement of the anterior tongue and floor of the mouth. A biopsy confirmed squamous cell carcinoma, a common form of oral cancer. Further evaluation with a whole-body PET scan showed that the tumour had extended deep into the tissues, reaching the hyoid bone.”

He added that considering the advanced stage of the disease and the patient’s young age, the multidisciplinary tumour board recommended chemotherapy given before surgery (neoadjuvant chemotherapy) to shrink the tumour and improve surgical outcomes. “After two cycles of chemotherapy, follow-up PET scans showed a good partial response, following which the patient was reassessed and taken up for surgery,” he said.

In his comments Dr. Sivaram Ganesamoni said, “This case highlights the integration of multimodality expertise in action, delivering results even in a seemingly impossible clinical scenario. Each one of the specialists involved are to be commended for the clinical excellence.”

Explaining the surgical procedure, Dr. Manikandan Venkatasubramaniyan said, “The surgery involved an anterior total glossectomy, which is the complete removal of the front portion of the tongue, along with resection of the entire floor of the mouth. In addition, a segmental mandibulectomy was performed to remove the affected part of the jaw bone on the right side, and the hyoid bone was also removed. To restore the large surgical defect and preserve function, the team carried out advanced reconstruction using a Free Anterolateral Thigh (ALT) flap, in which healthy tissue from the patient’s left thigh was transplanted to rebuild the removed structures. The patient is disease free and is back to his routine life.”

RYA Cosmo Foundation to Host Fundraising Musical Evening Featuring Anuv Jain in Chennai

Chennai, 4th January 2026: RYA Cosmo Foundation, a Chennai-based charitable trust committed to accessible healthcare and early disease detection under its MEDI BANK Project – “Care the Uncared” for the past three decades, is organizing a special fundraising musical evening featuring renowned singer-songwriter Anuv Jain held today at YMCA Grounds, Royapettah, Chennai, in association with Hivefy Events.
The concert aims to support and strengthen the Foundation’s flagship healthcare initiatives — Shanti Devi Jawaharmal Day Care and Diagnostic Centre and Manoharraj Kamala Kankaria Cancer Detection Centre, both of which have been serving the community with affordable, reliable, and quality medical services.
The Shanti Devi Jawaharmal Day Care and Diagnostic Centre provides comprehensive diagnostic and day-care medical facilities with a strong focus on early diagnosis, preventive healthcare, and affordable investigations, catering to people from all walks of life. The Manoharraj Kamala Kankaria Cancer Detection Centre is dedicated to early cancer screening and detection, playing a crucial role in identifying cancer at treatable stages.


Speaking about the Foundation’s mission, Managing Trustee Mr. Kalpesh Shah stated, “These initiatives reflect RYA Cosmo Foundation’s commitment to ‘Healthcare with Compassion and Accessibility’, especially for the underprivileged sections of society.”
Music for a Cause Fundraising Chairman Mr. Prasan Kankaria emphasized, “Music for a Cause” is the spirit of this event. The concert featuring Anuv Jain, whose soulful music resonates deeply with today’s youth, is expected to draw a large and diverse audience.


President Mr. Satish Munoth of RYA Cosmo Foundation added, “This concert is more than an evening of music—it is a collective step towards saving lives through early diagnosis and quality healthcare. We are grateful to our donors, Hivefy Events, and all supporters for standing with us in this noble cause.”
The event has been made possible through the dedicated efforts of the entire organizing team, including Manish Ranka, Sanjay Gundecha, Ajay Nahar, Chiragh Chowatia, Mahesh Taleda, Anil Kothari, Abhay Lodha, along with trustees and committee members.


RYA Cosmo Foundation invites citizens, corporates, donors, and music lovers to participate and contribute towards strengthening these life-saving healthcare initiatives.

Kauvery Hospital Launches One-Tap ‘SOS’ Feature on Kauvery KARE App to Deliver Faster Emergency Care


Chennai , 22nd December 2025: Kauvery Hospital today announced the launch of its one-tap ‘SOS’ emergency feature on the Kauvery KARE app, designed to simplify and accelerate access to emergency medical care. The feature enables users to receive immediate medical support with just a single tap, and without the need to remember emergency numbers or explain their location during critical moments.
In emergency situations, panic, confusion, or unfamiliar surroundings often make it difficult for patients or bystanders to communicate essential details to emergency services. Kauvery Hospital’s SOS feature addresses this challenge by automatically capturing the user’s location through GPS, allowing the nearest ambulance to be dispatched instantly to the exact location.
At the same time, the SOS feature enables the user or bystander to connect with a doctor from Kauvery via a 24/7 video call system, ensuring real-time medical guidance and reassurance until emergency help arrives. This seamless integration of ambulance services and live medical consultation helps bridge the crucial gap between the onset of an emergency and hospital care.
Speaking on the occasion, Mr Suresh Sambandam, Founder and CEO, Kissflow said, “ True innovation turns complex problems into simple solutions. Kauvery KARE does exactly that-putting lifesaving care with just one tap away. It is inspiring to see a Tamil Nadu leader using digital innovation to solve real world needs and create a massive impact.”


Speaking at the launch, Dr Aravindan Selvaraj, Co-Founder and Executive Director, Kauvery Group of Hospitals, said, “Today, mobile apps have become a natural part of how people manage their daily lives from mobility to basic essentials that reach them within minutes. When convenience and speed are already expected in these areas, healthcare cannot remain an exception. During medical emergencies, every second matters. During such moments it is natural for patient or their attenders to be worried and in times of panic they will be unable to reach out for help or explain their situation which can lead to delays. Our goal is to remove complexity from emergency care. With the Kauvery KARE SOS feature, help is just one tap away.”
Beyond emergency support, the Kauvery KARE app serves as a comprehensive digital healthcare platform. Individuals can book appointments across any Kauvery Hospital unit, opt for video or in-person consultations, access health reports digitally, and manage medical records for multiple family members on a single app. The app is available on iOS and Android.
The launch of Kauvery KARE reflects Kauvery Hospital’s commitment to using technology to enhance accessibility, responsiveness, and continuity of care. By combining emergency response with everyday healthcare services, the app aims to provide patients with a dependable, all-in-one digital health solution—available anytime, anywhere.

Buddhi Clinic Hosts Landmark “Neurofrontiers 2025”

Buddhi Clinic Hosts Landmark “Neurofrontiers 2025” International Neuropsychiatry Colloquium

INA–GNG Partnership Brings 25 Global Experts to Chennai to Shape the Future of Brain–Mind Care

CHENNAI, December 13, 2025 – Buddhi Clinic, which has firmly established Chennai as a global hub for neuropsychiatry innovation through its pioneering interventional and integrative neuropsychiatry and advanced neurorehabilitation paradigms, is hosting Neurofrontiers 2025: The INA–GNG Colloquium.

This landmark gathering brings together 25 internationally acclaimed experts from Johns Hopkins University & Kennedy Krieger Institute (USA), Brown University (USA), University of Melbourne (Australia), Imperial College London (UK), and other world-leading institutions. Their collective mission: to redefine clinical paradigms for complex neurological and neuropsychiatric conditions.

The International Neuropsychiatric Association (INA) and the Global Neuropsychiatry Group (GNG) have partnered with Buddhi Clinic for this high-impact colloquium, recognizing its alignment with the global movement toward advanced, interventional neuropsychiatry.

This collaboration is further strengthened by the leadership roles of Buddhi Clinic: Dr. Ennapadam S. Krishnamoorthy, Founder, served an extended term as President of the INA during the Covid-19 pandemic, and Mr. Vivek Misra, Director–Neurotechnology at Buddhi Clinic, now serves on the INA Executive Committee.

Buddhi Dialogue: The Intellectual Summit of Day Two

The highlight of the second day is the Buddhi Dialogue on New Frontiers in Neuropsychiatry, featuring three globally respected clinician-scientists:

Prof. Jay A. Salpekar (Johns Hopkins University & Kennedy Krieger Institute) – Childhood Epilepsy

Prof. W. Curt LaFrance Jr. (Brown University) – Functional Neurological Disorders

Prof. David Coghill (University of Melbourne) – Attention-Deficit/Hyperactivity Disorder

Moderated by Dr. Ennapadam S. Krishnamoorthy, this intimate session represents the intellectual pinnacle of the two-day program.

“This colloquium represents the materialization of our vision to position India at the vanguard of global neuropsychiatry,” said Dr. Krishnamoorthy. “We are not simply facilitating knowledge transfer—we are actively shaping the future of how complex brain disorders are understood and treated.”
A Scientific Program That Spans the Entire Brain–Mind Spectrum

Curated by Dr. Jasvinder Singh (Founder, GNG) and Mr. Vivek Misra, with scientific guidance from Prof. Valsamma Eapen (University of New South Wales; President, INA), the program covers major frontiers in contemporary neuropsychiatry:

Neurodevelopmental disorders, Autism Spectrum Disorders

Attention-deficit and behavioural disorders

Functional neurological disorders

Traumatic brain injury and metabolic neurology

Therapeutic neuromodulation and psychedelic therapies

Deep brain stimulation and brain–computer interfaces

Artificial intelligence in neuropsychiatric diagnostics and care

Hands-On Workshops: Bridging Research and Real-World Practice

On December 14, Neurofrontiers 2025 features two specialized workshops:

Integrated Functional Electrical Stimulation – Ms. Durga D. Gawade

Non-Invasive Brain Stimulation – Mr. Vivek Misra, Head of Neuromodulation, Buddhi Clinic

These workshops translate cutting-edge research into immediate clinical application, enabling practitioners to adopt state-of-the-art protocols.

Distinguished Global Faculty

The colloquium features prominent voices from leading neuropsychiatry centers, including:

Prof. Shoumitro Deb – Imperial College London

Prof. Helen Cross – Great Ormond Street Hospital

Prof. Maria Oto – University of Edinburgh

Prof. Valsamma Eapen – University of New South Wales

Prof. Urvakhsh Mehta – NIMHANS

Their presence underscores Chennai’s emergence as a world-stage venue for neuropsychiatric thought leadership.

A Hybrid Platform Connecting Continents

Proceedings at Buddhi Clinic, Teynampet, are delivered in a hybrid format, enabling global participation. Institutions such as Kasturba Medical College (KMC) Manipal are hosting interactive classrooms where postgraduate trainees and faculty engage live with the colloquium—democratizing access to elite scientific discourse.

About Buddhi Clinic

Founded in 2009, Buddhi Clinic is internationally recognized for its leadership in interventional and integrative neuropsychiatry.

With over 15,000 patients treated, the clinic offers a unique synthesis of:

18+ therapeutic modalities

Advanced neurotechnology (non-invasive brain stimulation, precision neuropsychiatric assessments)

Multidisciplinary clinical expertise

Ancient healing wisdom and holistic care

With centers in Chennai, Coimbatore, and Indore, Buddhi Clinic is redefining personalized care for complex disorders of brain and mind.

India’s First Arthroscopic Rotator Cuff Repair with Patch Augmentation using ArthroFlex® at Chennai Upper Limb Unit

Chennai, India 12th Dec 25:

 In a remarkable milestone for Indian orthopedic surgery, Dr. Ram Chidambaram, one of India’s foremost shoulder specialists, successfully performed the country’s first arthroscopic rotator cuff repair using ArthroFlex®–HDA, at Chennai Upper Limb Unit, Chennai. This pioneering procedure marks a significant leap forward in restoring shoulder function and improving quality of life for patients suffering from complex, massive rotator cuff tears.

Speaking on the occasion, Dr. Ram Chidambaram said: “This surgery opens new possibilities for patients who were previously considered untreatable with conventional methods. ArthroFlex–HDA provides an ideal graft for restoring shoulder biomechanics, giving patients a pain-free, functional shoulder and a renewed quality of life.”

Rotator Cuff Injuries Rotator cuff tears are commonly encountered following an injury or fall. The muscles making up the rotator cuff (crucial for lifting and shoulder rotation) often wear down with age and repetitive use, increasing their propensity to tear. Patients present with significant pain, restricted range of motion and hampered ability to perform activities of daily living. Small tears can be treated conservatively, but big tears often require surgical intervention in the form of arthroscopic repair (‘keyhole surgery’). Classically, this involves reattachment of the torn tendon to the footprint of the humeral head using suture anchors. The majority of patients respond well to this procedure, but a few experience poor functional outcomes due to degenerative tissue and retears.

The rotator cuff is essentially supported by a ‘Human allograft patch’ of tissue that holds the repair together, enabling faster post-operative mobilization and reducing risk of retear. Patients also experience tremendous pain relief and better functional outcomes. Human allograft patches advanced and superior, providing increased strength, elasticity and biocompatibility. The graft preserves native cellular architecture, allowing for long-term integration into host tissue.

 Chennai Upper Limb Unit is a dedicated specialist centre in Alwarpet that exclusively caters to patients with problems affecting the shoulder, elbow, wrist and hand. Dr Ram Chidambaram, founding director of the Chennai Upper Limb Unit, is a senior consultant shoulder & upper limb surgeon with over 30 years of experience in India and the UK. His expertise is in sports medicine and treating upper limb ailments and is now regarded as one of the best shoulder and upper limb surgeons in Asia

ArthroFlex®–HDA by Avana

 ArthroFlex®–HDA has been made available in India through the work of Avana Medical Devices Pvt Ltd. The company, founded in 2009 and headquartered in Chennai.  Avana is proud to have supported this landmark case by ensuring timely and compliant access to the human dermal allograft, said Mr. P Sundararajan, Managing Director at Avana Medical Devices Pvt Ltd. “Our goal is to bridge the gap between international innovation and Indian clinical needs, so patients here can benefit from world-class solutions without delay. We are always proud to introduce new technologies in India to enable surgeons to treat their patients better.”

SIMS Hospitals Performs India’s First Keyhole Removal of Rare Heart Tumour from the Left Ventricle

Chennai, December 10th, 2025: SIMS Hospitals successfully performed India’s first Endoscopic Left Ventricular tumour removal, a key hole minimally invasive surgery avoiding the need for breast bone cutting (sternotomy). This was done for a very rare tumour that has grown inside the heart’s main pumping chamber, in a 45-year-old female patient.

The patient, a working woman, incidentally diagnosed to have a mass attached to the main pumping chamber of the heart (the left ventricle). An MRI of the heart confirmed it to be a left ventricular mass/thrombus measuring 1.6 × 1.5 cm.

Primary cardiac tumours accounts for only about 0.6% of all cardiac surgeries performed in the country. Specifically, the left ventricular tumour is extremely rare, occurring in only about one in 20-30 million people. The usual approach for treating this condition is a sternotomy, an open-heart surgery. However, doctors at SIMS Hospitals opted for an endoscopic cardiac surgery, a minimally-invasive keyhole procedure. It involves creating small openings between the ribs, passing through the muscle, accessing the chambers of the heart, and removing the tumour.

The elective procedure successfully removed the tumour and eliminated the risk of complications like stroke. The surgery was performed by Dr. A. Mohammed Ibrahim, Consultant – Cardiothoracic Surgery under the guidance of Dr. V. V. Bashi, Director & Senior Consultant – Institute of Cardiac & Advanced Aortic Diseases. The surgery involved endoscopic guidance and specialised minimally invasive instruments to remove the tumour.

Congratulating the team on this historic achievement, Dr. Ravi Pachamuthu, Chairman, SIMS Hospital said, “This success reflects the strength of our clinical environment, the sophistication of our endoscopic capabilities and infrastructure, and above all the dedication and precision of our team. Together, we continue to uphold the highest standards of care and deliver hope and healing when it matters most.”

In his comments, Dr V. V. Bashi said, “Left ventricular mass is a rare condition, and performing its removal through a minimally invasive technique is exceptionally uncommon in the world. It is done for the first time in India. The patient was under general anesthesia and placed on heart-lung machine support through the blood vessels in the right groin. Through a tiny 3 cm incision, right chest cavity was approached. Right lung was collapsed, after the patient was initiated on heart-lung machine support. Heart was stopped and chambers of the heart were opened. Endoscope was used to visualise the main pumping chamber and the tumour was excised completely. The chambers were closed and the heart was allowed to beat. The patient was gradually weaned off the heart-lung machine. She is now completely normal and has resumed her routine work without any discomfort in two weeks.”

Commenting on the benefits of the key-hole surgery, Dr Mohammed Ibrahim said, “cardiac surgery generally involves cutting through the central sternal bone, which increases pain, hospital stay and the risk of morbidities. However, endoscopic cardiac surgery is an advanced minimally invasive approach that enables faster recovery while reducing pain and blood loss. It also avoids a prominently visible scar in the middle of the chest after surgery. Endoscopic assistance further enhances precision and allows us to access areas that may not otherwise be easily reachable. We have already performed five such cases with a 100% success rate. We also use minimally invasive approaches to treat other cardiac conditions such as coronary artery disease, valvular heart disease, septal defects of the heart, and mediastinal tumours. About 90% of cardiac tumours happen due to random changes in the heart’s cells, with no clear reason. The remaining 5-10% occur in people who have a genetic tendency to develop these tumours.

Billroth Hospitals Launches Institute of Robotic Surgery to Deliver High-Precision, Cost-Effective Care


● Robot-assisted surgery will be offered across oncology, gastrointestinal, urology, thoracic, gynaecology and complex general surgery specialties.
● The hospital will use the advanced SSi Mantra system, featuring modular robotic arms and high-definition 3D imaging for enhanced surgical precision.

Chennai, November 29, 2025

Billroth Hospitals, one of the city’s leading multispeciality centres and a pioneer in advanced laparoscopic and laser procedures, has launched its Institute of Robotic Surgery, marking a major expansion of its minimally invasive surgical capabilities. The facility will use the SSi Mantra 3, an India-made next-generation surgical robot designed by SS Innovations, to perform a wide range of procedures with greater precision and improved patient outcomes.

the robotic platform will be deployed across oncology, gastrointestinal surgery, urology, thoracic surgery, gynaecology and complex general surgery. The SSi Mantra 3 will also support intricate operations involving the esophagus, stomach, liver, pancreas, biliary system, intestines, rectum, anal canal and urological organs such as the kidney, ureter, bladder and prostate. It will further aid minimally invasive interventions for reproductive tract conditions, retroperitoneal tumours and tumours of the chest.

The hospital said that the system will enhance its capabilities in performing complex hernia repairs, bile duct exploration, diaphragmatic repair, hiatus hernia fundoplication, metabolic and bariatric surgery, hysterectomy and tubal reimplantation. High-end procedures such as liver transplantation and cardiac bypass are also expected to benefit from the dexterity and stability offered by the robotic arms.

The SSi Mantra 3 features 3 to 5 fully modular robotic arms and supports more than 40 robotic endo-surgical instruments, enabling surgeons to tailor the setup to each operation. Its open-face console includes a 32-inch 3D 4K display, ergonomic controls and head-tracking safety, offering enhanced visual clarity and steadier control during long or complex surgeries.

In his comments, Dr. Rajesh Jeganathan, Chairman, Billroth Hospitals said, “We are pleased to launch a centre of excellence for robot-assisted surgery. Our goal is to democratise minimally invasive care by making it accessible and affordable for our patients. Those who require laparoscopic procedures should consider robotic surgery, as both follow the same minimally invasive principles. With a robot-assisted approach, even complex operations can be performed more safely, with faster recovery and shorter hospital stays – ultimately reducing overall treatment costs. This is especially beneficial for cancer patients who need intricate resections or long surgical hours. The minimally invasive technique also enables patients to get out of bed the very next day, significantly supporting quicker recovery.”

He further added that robotic technology significantly enhances surgical precision. Unlike conventional open surgery, robotic systems provide a highly magnified, 10x enlarged 4K 3D view that offers exceptional clarity while preserving the depth perception of open procedures. The stable robotic platform minimises unintended hand movements, enabling greater accuracy and reducing blood loss. With a range of motion that exceeds natural human limits, the robotic arms can bend and rotate to access difficult-to-reach areas with ease. Importantly, surgeons operate from an ergonomically designed console, which reduces fatigue and allows for steadier control during long or complex surgeries.

SRM Prime Opens GI and Liver Institute with South India’s Most Advanced Endoscopy Unit

Chennai, November 03, 2025: SRM Prime Hospital, Ramapuram, a leading multispecialty hospital in the city, has launched the SRM Prime Institute of Gastrointestinal and Liver Diseases, an exclusive centre featuring South India’s most advanced endoscopy unit to offers comprehensive gastroenterology services and precision-driven digestive care for patients across all age groups.

Tamil film actor R. Parthiban inaugurated the institute in the presence of Mr. P. Siva, Chief Executive Officer, Dr. Arulprakash, Clinical Lead & Senior Consultant – Gastroenterology and Hepatology, Dr. Tharun J George, Senior Consultant – Gastroenterology and Hepatology, SRM Prime Hospital, Ramapuram, Chennai.

Led by a team of expert gastroenterologists, the newly launched institute features cutting-edge equipment such as the Arietta 750 and EP-8000 endoscopic ultrasound systems, offering high-resolution imaging with the Olympus X1 platform. These advanced systems enable precision-guided, minimally invasive procedures for gastrointestinal and liver diseases. The introduction of the Slim Therapeutic Endoscope EG-840TP further enhances procedural manoeuvrability, ensuring accurate diagnosis, effective treatment, and faster recovery.

Speaking on the occasion, Mr. P. Siva said: “At SRM Prime Hospital, our vision is to deliver comprehensive digestive care under one roof—combining world-class technology with a highly skilled team of gastroenterologists and trained nursing staff. With this new institute, we reinforce our position as a centre of excellence in gastroenterology. From advanced imaging and minimally invasive procedures to 24/7 emergency care for GI bleeds and foreign body removals, we remain committed to providing precise, high-quality, and patient-friendly digestive care that meets global standards.”

Dr. Arulprakash added: “The institute offers complete gastroenterology and liver care, addressing diseases of the esophagus, stomach, intestine, gallbladder, pancreas, and liver. Our state-of-the-art endoscopy suites ensure safe and painless procedures using gentle sedation, performed by expert gastroenterologists. We specialise in advanced, minimally invasive endoscopic treatments that eliminate the need for major surgeries and enable faster recovery. Our advanced endoscopic ultrasound, the first of its kind in Tamil Nadu, enables detailed imaging and targeted interventions for complex pancreatic and biliary conditions. Our team also specialises in small bowel endoscopy and GERD endoscopic treatment. Using cutting-edge technology, we are equipped to detect early GI cancers and perform non-surgical removals through advanced techniques such as ESD, EMR, and EFTRD.”

The SRM Prime Institute of Gastrointestinal and Liver Diseases provides advanced, minimally invasive solutions for digestive health—including early gut cancer treatment, swallowing therapy, acid reflux management, and advanced ERCP & Endoscopic Ultrasound–guided interventions for liver and pancreas disorders. It is equipped for the treatment of bile duct and pancreatic stones using advanced cholangioscopy and laser stone fragmentation. The institute also offers bariatric endoscopy options such as Endoscopic Sleeve Gastroplasty (ESG) and Intragastric Balloon therapy for obese patients.

SRM Prime houses a range of specialised clinics, including the Acid Reflux Clinic, Constipation & GI Motility Clinic, Pancreas Clinic, Liver Clinic, Obesity & Metabolic Endoscopy Clinic, and the IBD (Crohn’s & Ulcerative Colitis) Clinic. The institute provides 24/7 gastrointestinal emergency and critical care, handling urgent cases such as GI bleeding, foreign body removal, acute pancreatitis, and liver-related emergencies—ensuring rapid, expert intervention whenever needed.